Ulys A, Jankevicus F, Jievaltas M, Venckus R, et al. Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trial. Prostate 2024 Feb 4. doi: 10.1002/pros.24674.
PMID: 38311868